Skip to search.
 FTSE 100 Down 0.48%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
8.57 Down 0.57(6.24%) 24 Aug 21:00
|After Hours: : 9.00 Up 0.43 (5.02%) 23:21
Prev Close:9.14
Open:9.14
Bid:8.60 x 100
Ask:9.00 x 1000
1y Target Est:19.75
Beta:1.80181
Earnings Date:7 Nov - 11 Nov (Est.)
Day's Range:8.50 - 9.24
52wk Range:4.50 - 11.69
Volume:1,636,132
Avg Vol (3m):1,525,080
Market Cap:630.31m
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for INO at this time.

Comparison

Symbol% ChgMkt Cap
INODown 6.24%630.31m
PFEDown 0.77%211.21b
AZNDown 0.98%84.76b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.93
Quarterly EPS Est (Sep-16) :-0.27
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback